Who we are

BioCurate is a bold, collaborative venture, dedicated to translating Australia’s research potential to drive economic returns and health impacts worldwide. Created jointly by two of Australia’s leading biomedical universities – the University of Melbourne and Monash University – with the support of the Victorian government, we identify promising biomedical research and help accelerate its development into new therapies. We are operationally independent, with a team that brings decades of scientific and commercial expertise, enabling us to recognise and realise real-world potential and providing a critical bridge, aligning the efforts and interests of industry and academia.
We can help you change the future.

We bridge the gap

Our collaborative team of global biomedical experts bridge the gap between:

Academia + Industry
Ideas + Impact
Focus + Collaboration
Collaboration + Commercialisation
Research + Translation

What we are doing

The BioCurate team

Our team

Has over 200 years of combined biotech/pharma industry experience

Has been directly involved in over 39 Investigational New Drug applications (INDs)

Are responsible for 72 therapeutics currently in the clinic

Were directly involved in 15 deals worth a cumulative total of more than $3.9 billion

Twitter feed

“Greatly honoured to receive @BioCurate 'Proof of Concept' funding to advance research on targeted treatments for #breastcancer in collaboration with Prof Yeesim Khew-Goodall @CCB_Research @UniMelbMDHS @SciMelb

The second award under BioCurate’s new Proof of Concept fund has been granted to Prof Michael Parker from @Bio21Institute, in collaboration with Prof Yeesim Khew-Goodall from @CCB_Research. Read more https://bit.ly/3BD9l7E

BioCurate sponsored second prize at the @ASCEPTanz Student Forum Symposium, which was won by @Ranita_Histac from @UNSW for her presentation "A population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients." Congratulations to all the winners!

BioCurate is a proud supporter of #AusBio21, providing the prize for the Best Project at the Early-Stage Investment Forum. Register now to join Australia's largest life sciences and biotech conference.